Consolidated cash flow statements
(unaudited)
|
Six months ended 30 June |
|
---|---|---|
(thousands of €) |
2024 |
2023 |
Net profit of the period |
99,205 |
28,308 |
|
|
|
Adjustment for non-cash transactions |
(14,184) |
47,603 |
Adjustment for items to disclose separately under operating cash flow |
(49,814) |
(13,155) |
Adjustment for items to disclose under investing and financing cash flows |
(62,075) |
(7,123) |
Change in working capital other than deferred income |
(64,496) |
(18,545) |
Cash used for other liabilities related to the disposal of subsidiaries |
(3,598) |
- |
Decrease in deferred income |
(140,038) |
(264,931) |
Cash used in operations |
(235,000) |
(227,843) |
|
|
|
Interest paid |
(501) |
(3,472) |
Interest received |
47,228 |
12,125 |
Corporate taxes paid |
(594) |
(1,096) |
Net cash flow used in operating activities |
(188,867) |
(220,286) |
Purchase of property, plant and equipment |
(7,062) |
(8,065) |
Purchase of and expenditure in intangible fixed assets |
(65,036) |
(28) |
Proceeds from disposal of property, plant and equipment |
- |
2,212 |
Purchase of current financial investments |
(1,516,737) |
(2,212,112) |
Investment income received related to current financial investments |
9,558 |
5,356 |
Sale of current financial investments |
1,717,044 |
2,024,877 |
Cash out from the disposals of subsidiaries, net of cash disposed of |
(5,209) |
- |
Acquisition of financial assets held at fair value through other comprehensive income |
(36,880) |
- |
Net cash flow generated from/used (–) in investing activities |
95,678 |
(187,760) |
|
|
|
Payment of lease liabilities |
(2,232) |
(3,511) |
Proceeds from capital and share premium increases from exercise of subscription rights |
- |
1,770 |
Net cash flow used in financing activities |
(2,232) |
(1,741) |
|
|
|
Decrease in cash and cash equivalents |
(95,421) |
(409,787) |
|
|
|
Cash and cash equivalents at beginning of the period |
166,810 |
508,117 |
|
|
|
Decrease in cash and cash equivalents |
(95,421) |
(409,787) |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
939 |
(306) |
|
|
|
Cash and cash equivalents at end of the period |
72,328 |
98,024 |
The accompanying notes form an integral part of these condensed consolidated financial statements.